6,665 Danaher Corporation $DHR Shares Acquired by Financial Enhancement Group LLC

Financial Enhancement Group LLC raised its stake in shares of Danaher Corporation (NYSE:DHR) by 57.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 18,169 shares of the conglomerate’s stock after buying an additional 6,665 shares during the period. Financial Enhancement Group LLC’s holdings in Danaher were worth $4,025,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. EP Wealth Advisors LLC purchased a new position in Danaher in the second quarter worth about $3,807,000. Puzo Michael J bought a new position in shares of Danaher in the 2nd quarter worth approximately $8,624,000. Madison Asset Management LLC bought a new position in shares of Danaher in the 2nd quarter worth approximately $85,451,000. First Nebraska Trust Co purchased a new position in shares of Danaher in the second quarter worth approximately $14,106,000. Finally, Colton Groome Financial Advisors LLC purchased a new position in shares of Danaher in the third quarter worth approximately $592,000. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on DHR. TD Cowen reduced their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Barclays boosted their price objective on shares of Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research report on Wednesday. Evercore reaffirmed an “outperform” rating and issued a $230.00 target price on shares of Danaher in a report on Monday, July 6th. Finally, The Goldman Sachs Group lifted their target price on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research report on Monday, September 21st. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $235.23.

Danaher Stock Performance

NYSE DHR traded down $1.16 on Thursday, reaching $217.33. 5,292,542 shares of the stock were exchanged, compared to its average volume of 4,464,317. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a market capitalization of $152.78 billion, a PE ratio of 38.60, a PEG ratio of 2.68 and a beta of 0.76. The company’s 50-day simple moving average is $210.88 and its two-hundred day simple moving average is $194.44.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business posted $0.77 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. Analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.